Kowa/Lilly's statin Livalo beats pravastatin in LDL-C lowering in Phase IV study
04:05 EDT 4 Jun 2012 | SCRIP
Kowa Pharmaceuticals America's and Eli Lilly's Livalo (pitavastatin) met its primary endpoint in the Phase IV PREVAIL clinical trial when it proved superior to pravastatin (Bristol-Myers Squibb's Pravachol) in lowering low-density.....
Original Article: Kowa/Lilly's statin Livalo beats pravastatin in LDL-C lowering in Phase IV study
More From BioPortfolio on "Kowa/Lilly's statin Livalo beats pravastatin in LDL-C lowering in Phase IV study"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
